CP and Wilson disease: In clinical practice, PA is primarily used to treat copper metabolism disorders and is a key medication for managing conditions such as Wilson’s disease (WD), exerting systemic effects through high-affinity binding to non-ceruloplasmin-bound copper in the plasma (35, 36).